DEERFIELD MANAGEMENT COMPANY, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001009258

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2025 · 118 positions · Total reported value $4.58B · Top-10 concentration 56.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.6% · 10 new · 12 cut · 12 exited

Active Share (vs S&P 500): 99.6% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +17.1% · vs SPY +2.2% · Prev Value $7.59B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2025 13F filing, DEERFIELD MANAGEMENT COMPANY, L.P. disclosed 118 equity positions with a combined reported value of $4.58B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 56.2% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were NUVL ($1.28B), VTRS ($208.97M), NBIX ($164.68M). By sector, the heaviest allocations are Health Care 60.5%, Industrials 1.5%. Versus the prior quarter, allocation shifted toward Health Care (+1.9pp) and away from Technology (-1.8pp).

Versus the prior quarter, DEERFIELD MANAGEMENT COMPANY, L.P. opened 10 new positions, trimmed 12 and fully exited 12, a turnover rate of 38.6% of positions. The portfolio's overlap with the prior quarter was 50% of names.

The largest new positions opened in Q1 2025 were UTHR ($84.84M), PFE ($84.82M), INSM ($34.94M).

Of the 12 positions fully exited versus the prior quarter, the largest were WAY ($120.94M), ACH ($64.20M), LKFT ($38.80M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • UTHR UNITED THERAPEUTICS CORP DEL · $84.84M
  • PFE PFIZER INC · $84.82M
  • INSM INSMED INC · $34.94M
  • VERA VERA THERAPEUTICS INC · $25.22M
  • LQDA LIQUIDIA CORPORATION · $23.85M
  • PRAX PRAXIS PRECISION MEDICINES I · $23.48M
  • CERT CERTARA INC · $20.02M
  • XERS Xeris Biopharma Holdings Inc · $19.93M

Fully Exited (vs previous quarter)

  • WAY WAYSTAR HLDG CORP · prev qtr: $120.94M
  • ACH ACCENDRA HEALTH INC · prev qtr: $64.20M
  • LKFT LAKEFRONT BIOTHERAPEUTICS NV · prev qtr: $38.80M
  • BCAX BICARA THERAPEUTICS INC · prev qtr: $31.27M
  • SEPN SEPTERNA INC · prev qtr: $19.74M
  • RXRX RECURSION PHARMACEUTICALCLASS A · prev qtr: $15.65M
  • IRTC IRHYTHM HOLDINGS INC · prev qtr: $14.07M
  • ACCD ACCOLADE INC · prev qtr: $11.88M

Insider Transactions (Form 4)

Latest DEERFIELD MANAGEMENT COMPANY, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-15 D Nuvalent, Inc. 3,444 $124.00 SEC filing
2026-07-15 U Nuvalent, Inc. 5,146 $124.00 SEC filing
2026-07-15 D Nuvalent, Inc. 650,000 $124.00 SEC filing
2026-07-15 D Nuvalent, Inc. 8,299,225 $124.00 SEC filing
2026-06-16 Award Nuvalent, Inc. 3,444 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 407,132 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 260,992 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 149,238 — SEC filing

All insider transactions →

Fund Profile

Deerfield Management Company, L.P. is a New York-based hedge fund founded by Marianne and James Chadwin, known for its quantitative and fundamental research approach focused primarily on healthcare and biotechnology investments.

Investment Approach

Combines quantitative analysis with fundamental research

Specializes in healthcare and biotechnology sectors

Utilizes both public and private investment strategies

Asset Classes & Strategy

Primarily focused on long/short equity positions

Specializes in healthcare and biotechnology investments

Also invests in other sectors with strong fundamental research

Key Personnel

Marianne Chadwin (Co-founder)

James Chadwin (Co-founder)

Team of experienced portfolio managers and researchers

AUM & Performance

Manages approximately $19.1 billion in assets under management

Performance data not publicly disclosed

All information is based on publicly available SEC filings and company disclosures.

Sector Allocation

Health Care 60.5%
Technology 0.6%
Materials 0.0%
Utilities 0.0%
Other 36.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 17.99M $1.28B 27.89%
27.89%
Hold
2 23.99M $208.97M 4.57%
4.57%
Hold
3 1.49M $164.68M 3.60%
3.60%
Add
4 2.67M $162.21M 3.54%
3.54%
Hold
5 11.84M $155.23M 3.39%
3.39%
Hold
6 3.17M $133.59M 2.92%
2.92%
Add
7 10.51M $132.27M 2.89%
2.89%
Hold
8 3.32M $117.30M 2.56%
2.56%
Add
9 70.00M $114.51M 2.50%
2.50%
Hold
10 9.71M $105.27M 2.30%
2.30%
Hold
11 10.57M $100.71M 2.20%
2.20%
Add
12 15.61M $97.73M 2.14%
2.14%
Hold
13 4.57M $85.05M 1.86%
1.86%
Reduce
14 275.23K $84.84M 1.85%
1.85%
New
15 3.35M $84.82M 1.85%
1.85%
New
16 4.10M $84.01M 1.84%
1.84%
Reduce
17 3.42M $82.99M 1.81%
1.81%
Add
18 5.19M $67.33M 1.47%
1.47%
Hold
19 1.92M $65.83M 1.44%
1.44%
Hold
20 1.74M $59.16M 1.29%
1.29%
Add
21 226.07K $55.06M 1.20%
1.20%
Add
22 3.27M $53.52M 1.17%
1.17%
Add
23 2.08M $45.73M 1.00%
1.00%
Hold
24 21.23M $45.65M 1.00%
1.00%
Hold
25 5.00M $43.93M 0.96%
0.96%
Hold
26 145.00K $39.15M 0.86%
0.86%
Hold
27 5.19M $38.92M 0.85%
0.85%
Reduce
28 782.33K $38.84M 0.85%
0.85%
Add
29 611.00K $36.90M 0.81%
0.81%
Hold
30 2.02M $34.95M 0.76%
0.76%
Add
31 458.00K $34.94M 0.76%
0.76%
New
32 2.72M $34.69M 0.76%
0.76%
Reduce
33 3.77M $32.09M 0.70%
0.70%
Hold
34 2.02M $31.67M 0.69%
0.69%
Hold
35 3.86M $29.23M 0.64%
0.64%
Add
36 1.58M $28.01M 0.61%
0.61%
Hold
37 1.01M $25.81M 0.56%
0.56%
Reduce
38 1.05M $25.22M 0.55%
0.55%
New
39 1.62M $23.85M 0.52%
0.52%
New
40 2.96M $23.48M 0.51%
0.51%
Add
41 619.93K $23.48M 0.51%
0.51%
New
42 240.22K $23.45M 0.51%
0.51%
Hold
43 7.96M $22.06M 0.48%
0.48%
Hold
44 850.70K $20.83M 0.46%
0.46%
Hold
45 500.00K $20.40M 0.45%
0.45%
Hold
46 2.02M $20.02M 0.44%
0.44%
New
47 10.50M $19.93M 0.44%
0.44%
New
48 794.87K $17.48M 0.38%
0.38%
Reduce
49 877.81K $17.14M 0.38%
0.38%
New
50 593.00K $16.23M 0.35%
0.35%
Hold

FAQ

What did DEERFIELD MANAGEMENT COMPANY, L.P. buy in 2025-Q1?

In its 2025-Q1 13F filing, DEERFIELD MANAGEMENT COMPANY, L.P. reported 118 equity positions worth $4.58B in aggregate; its largest disclosed positions were NUVL ($1.28B), VTRS ($208.97M), NBIX ($164.68M).

How large is DEERFIELD MANAGEMENT COMPANY, L.P.'s portfolio?

DEERFIELD MANAGEMENT COMPANY, L.P. reported $4.58B of long equity holdings across 118 positions as of 2025-Q1. Top-10 holdings account for 56.2% of reported value.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deerfield-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →